Curcumin inhibits<i>in vitro</i>and<i>in vivo</i>chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21
Simona Taverna(Istituto di Farmacologia Traslazionale), Riccardo Alessandro(Institute for Biomedical Research and Innovation), A. Flugý(University of Palermo), Marzia Pucci(University of Palermo), Marco Giallombardo(Antwerp University Hospital), Christian Rolfo(Icahn School of Medicine at Mount Sinai), Mauro Manno(Instituto di Biofisica), Samuele Raccosta(Instituto di Biofisica), Giacomo De Leo(University of Palermo)
Cited by 138
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642